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The aim of this study was to analyze and describe the epidemiological characteristics and trends of thyroid cancer in the province
of Sassari (Sardinia, Italy), an area with epidemic thyroid goiter, in the period 1992–2010. Data were obtained from the local tumor
registry whichmakes part of a wider registry web, coordinated today by the Italian Association for Tumor Registries. An increasing
trend in the incidence of thyroid cancer in the province of Sassari was evidenced.This trend seems to follow the general worldwide
trend and does not seem to be related to the high incidence of thyroid goiter in the area.The frequencies of the different histological
subtypes were similar to those reported in numerous national and international reports. Women are affected earlier than men and,
therefore, suffer greater professional, economic, and social impacts.Overallmortality is low and a relative 5-year survival is excellent,
especially in comparison to other malignancies.
1. Introduction
Thyroid cancer accounts for approximately 2% of all cancers
diagnosed worldwide and 95% of all endocrine cancers [1].
Recent reports describe a continuous increase in thyroid
cancer incidence worldwide. In certain geographical areas,
this increase exceeds 100% (and is as high as 250% in some
cases) [2]. By contrast, small declines in incidence were
registered in a few areas [2]. It has been suggested that this
generally steady trend of increasing thyroid cancer incidence
may be only apparent, and that it depends on higher detection
rates of small tumors due to the technological advances in
morphological and functional imaging techniques over the
last few decades [3].
Thyroid goiter is a pathological condition with epidemic
dimensions in some areas because of several geographical,
nutritional, and genetic factors. It has been linked to a higher
risk of thyroid cancer, especially the follicular histotype [4].
The aim of this population-based study was to analyze
and describe the epidemiological characteristics and trends
of thyroid cancer in the province of Sassari (Sardinia, Italy),
an area with epidemic thyroid goiter, in the period 1992–2010.
2. Materials and Methods
The epidemiological data presented in this paper were
obtained from the “Registry of the Tumors of the province
of Sassari.” This registry was created in 1992 by the local
health agency for the epidemiological surveillance of tumors
in the province. In 1999, it became part of a wider web of
tumor registries, coordinated today by the Italian Association
for Tumor Registries (Associazione Italiana Registri Tumori
(AIRTUM)). The association coordinates 34 registries in the
country, collects and publishes data, and collaborates with
international organizations in the field.
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Every registry collects data on tumoral diseases affecting
inhabitants in the territory of jurisdiction through the local
hospitals and health care services, as with other registries
(e.g., death registries). Demographic, clinical, pathological,
and prognostic data are collected for each case of cancer and
are registered in a digital database.This database was the data
source for the present population-based report.
The demographic characteristics of the patients affected
by thyroid cancer were collected. Crude incidence and mor-
tality rates per 100,000 inhabitants per year were calculated,
as were standardized rates adjusted for European population
standards. A comparison between incidence andmortality in
the province of Sassari and those in other Italian provinces
was performed. Additionally, the cumulative risk of develop-
ing the disease and of dying between zero and 74 years of age
was estimated. The age class distribution and time trends of
incidence, mortality, mean age of disease onset, and histology
were also evaluated. Finally, a relative 5-year survival was
calculated.
3. Results
The overall number of cases of thyroid cancer registered was
1,108. Diagnosis was confirmed by histological or cytological
reports in 1,089 cases (98.3%) and using other information
sources (clinical reports, death certifications, etc.) in the
remaining 19 cases (1.7%). Among the 1,108 individuals
registered, 237 were males and 871 females, with a male-to-
female ratio of 1 : 3.7. The mean age was 52.7 years for males
and 50.7 years for females. The cumulative risk of developing
the disease was 0.42% for males and 1.49% for females.
The crude incidence of thyroidmalignancies in the period
under investigationwas 5.8/100,000 formen and 20.5/100,000
for women. Standardized incidence rates were 5.2/100,000 for
males and 18.4/100,000 for females.
Table 1 shows the distribution of incidence in relation to
age in percentages while Table 2 shows the distribution of
incidence rates in relation to age. Peak incidence occurred
at 80–84 years for males and at 50–54 years in females. Inci-
dence rates were also calculated for the following three time
periods: 1992–2000, 2001–2005, and 2006–2010 (Figure 1).
There was a progressive increase in the incidence rate in
males, from 3.37/100,000 in the first period to 5.87/100,000
in the second period and 8.13/100,000 in the last period.
The corresponding figures for females were 11.85/100,000,
22.14/100,000, and 26.93/100,000, respectively. A twofold
increase in incidence occurred between 1992 and 2010.
Analysis of the trend ofmean age at disease onset for the same
periods of time did not reveal any relevant changes (Figure 2).
Concerning histology, 866 lesions (79.5%) were papillary
tumors, 123 (11.3%) follicular, 20 (1.8%) medullary, and 28
(2.6%) other histological subtypes. In the remaining cases
(4.8%), the exact histotype was not specified. An increasing
trend with regard to the principal histotypes (papillary and
follicular) was observed from 1992 to 2010, while medullary
and other rare histotypes remained stable (Figure 3).
Table 3 shows the comparison of the incidence and







































Figure 2: Trends of mean age at disease onset and death.
Table 1: Age-class incidence distribution.








provinces. There were 71 deaths in the period under investi-
gation (32males and 39 females). Crude overall mortality was
0.8/100,000 for males and 0.9/100,000 for females. Mean age
at death was 67.9 years in males and 74.2 years in females.
Standardized mortality rates were 0.8/100,000 for females
and 0.6/100,000 for males. The cumulative risk of death was
extremely low (0.05% for males and 0.04% for females).
Table 2 shows the age-class distribution of mortality rates.
There was a steady increase in mortality in relation to age
after the fifth decade of life. Figure 1 shows the time trend of
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Males Females Males Females
0–4 0 0 0 0
5–9 0 0 0 0
10–14 0.9 0.5 0 0
15–19 1.1 5.2 0 0
20–24 2.7 7.6 0 0
25–29 4.6 14.6 0.6 0
30–34 2.3 20 0 0
35–39 4.8 27 0 0
40–44 7.6 23 0 0
45–49 9.8 33.8 1.4 0.3
50–54 7.4 35.1 0 0
55–59 9.7 35 0.8 1.2
60–64 11.7 34.2 1.4 0.4
65–69 10.9 33.2 2.6 3.6
70–74 9.8 31 2.6 2.1
75–79 12.8 22.8 3.7 6.7
80–84 13 13.1 5.8 4.7
85+ 5.9 10.8 7.9 7.6























Figure 3: Trend of histological subtypes rates.
mortality between 1992 and 2010; there were no significant
changes. Finally, a relative 1-year survival was approximately
96.5%. Relative survival at 5 years from diagnosis was 92%.
4. Discussion
Thyroid cancer accounts for approximately the 2% of all
cancers diagnosed worldwide and 95% of all endocrine
cancers [1]. Recent data suggest there weremore than 213,000
new cases of thyroid cancer worldwide in 2008, with a
crude incidence rate of 3.1/100,000 and a cumulative risk of
developing the disease of 0.31 [5]. The male-to-female ratio







Males Females Males Females
Alto Adige 3.2 6.1 0.9 1
Biella 4.2 9.5 0.7 0.6
Ferrara 8.1 24.7 0.6 0.5
Firenze 4.2 12.9 0.5 0.7
Friuli V.G. 3.6 12.8 0.6 0.9
Genova 4.5 12.9 0.5 0.5
Macerata 3.7 8 0.4 0.5
Modena 7 18.9 0.4 0.6
Napoli 4 10.8 0.9 0.7
Parma 6.1 17.1 1 0.5
Ragusa 2.8 8.7 0.3 0.8
Reggio
Emilia 2.8 20.3 0.3 0.5
Romagna 5.3 18 0.4 0.7
Salerno 4.2 14.6 0.8 0.8
Sassari 3.9 15 0.8 0.6
Torino 3.1 10.4 0.3 0.7
Trento 2.9 9.4 0.4 0.7
Umbria 4.5 12.4 0.6 0.6
Varese 4.2 9.5 0.5 0.3
Veneto 3.4 10.1 0.4 0.6
MEAN 4.5 13.7 0.6 0.7
was approximately 1 : 3.3, while the crude incidence for men
was 1.4/100,000 and that for women was 4.9/100,000. The
cumulative risk was 0.15 for males and 0.47 for females [5].
Concerning the Italian population, we obtained informa-
tion using the same data source, and the following picture
for 2008 was created: 7,448 new cases (1,618 males and 5,830
females), a crude incidence of 12.5/100.000 (5.6 for males and
19 for females), and a cumulative risk of 0.88 (0.4 for males
and 1.35 for females). Italy ranks third in Europe in terms of
new cases, after the Russian Federation and France [5].
The standardized incidence of thyroid cancer in the
province of Sassari was similar to that estimated for the entire
country (Table 3). This is somewhat surprising as Sardinia is
an area of epidemic thyroid goiter, which is associated with
increased incidence of cancer, particularly the follicular type
[3]. This seems not to be the case in our province, where
the percentage of follicular thyroid cancers was similar to
that in large national and international reports, with only a
slight tendency to increase from 1992 to 2010. Our findings
are confirmed by surgical reports published by surgeons
employed in local hospitals. In these reports, less than 30%
of the patients who underwent thyroidectomy for thyroid
disease were affected by cancer and the percentage of the fol-
licular subtype, as determined by pathological examination
of surgical specimens, was comparable to that found in the
present study [6].
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Comparisons of the incidence rates with those of other
Italian provinces place our province approximately in the
middle, between provinces with higher incidences, such as
Ferrara, Modena, and Reggio Emilia, and provinces with
lower incidences, such as Ragusa and Trento.
Considering the distribution of the disease in relation
to age, only approximately 10% of the cases occurred in
individuals younger than 30 years and older than 75. More
than half of the cases were observed in individuals aged 45–
74 years. It is interesting to observe that the peak incidence
in men occurred at age 80–84 years, while in women it
occurred earlier (at 50–54 years of age). This has relevant
clinical, prognostic, and social consequences. While women
generally develop the disease earlier in their lives, when they
are professionally active and have a long life expectancy, men
develop the disease later, probably after their retirement from
work and when their life expectancy and probability of dying
from the disease are lower.
The time trends analysis showed a stable increase in
incidence in the province of Sassari. This trend is common
in numerous national and international geographical areas,
which have contributed to the global increase in the number
of new thyroid cancer cases reported in several publications.
As we mentioned before, in certain geographical areas such
increases are greater than 100% and as high as 250% in some
cases [2]. It is not clear whether this is a real increase in
incidence, as was demonstrated in some areas after nuclear
incidents, or whether it reflects a general improvement in the
technological means and expertise employed to detect small
thyroid malignancies, which in the past may have remained
undiscovered [3, 7]. Several autopsy studies demonstrated a
prevalence of thyroid microcarcinomas ranging from 2% to
35% [8, 9].
Concerning mortality, only 71 deaths occurred in the 18
years we studied. Crude overall mortality was 0.8/100,000 for
men and slightly superior for women (0.9/100,000). These
values are similar to those observed in other provinces in
Italy and in recent European reports [5, 10], but somewhat
higher than some worldwide estimates [5]. Considering the
age-class mortality trend, a natural increase in relation to
age was observed in both sexes, with peaks after the eighth
decade of life and without significant variations between 1992
and 2010. The relative 5-year survival was lower in males
than in females, but by global standards it can be considered
excellent, especially in relation to other types ofmalignancies,
and suggests that a good local health care system is available
for the sufferers.
5. Conclusions
Our data show an increasing trend in the incidence of thyroid
cancer in the province of Sassari. This trend seems to follow
the general worldwide trend and does not seem to be related
to the high incidence of thyroid goiter in the area. The
frequencies of the different histological subtypes were similar
to those reported in numerous national and international
reports. Women are affected earlier than men and therefore
suffer greater professional, economic, and social impacts.
Overall mortality is low and a relative 5-year survival is
excellent, especially in comparison to other malignancies.
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